BioStem Technologies, Inc. (BSEM)

BioStem Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	58.01	16.69	6.88	4.34	2.52	2.63
Revenue Growth (YoY)	1141.52%	142.69%	58.38%	72.14%	-4.13%	158.59%
Cost of Revenue	3.55	1.49	0.88	1.47	1.27	1.32
Gross Profit	54.46	15.2	5.99	2.87	1.25	1.31
Selling, General & Admin	54.16	22.63	10.43	4.19	3.09	7.04
Research & Development	0.41	0.34	0.12	0.12	0.06	0
Other Operating Expenses	-0	0	0	0.03	0	0
Operating Expenses	54.63	22.97	10.67	4.47	3.09	7.04
Operating Income	-0.16	-7.78	-4.68	-1.61	-1.84	-5.73
Interest Income	0	0	0	0	0	0.01
Interest Expense	0.74	0	0.47	0.53	0.53	0.63
Other Expense / Income	-0.53	0.7	1.49	-1.28	-0	-0.64
Pretax Income	-0.54	-8.48	-7.11	-1.41	-2.37	-6.35
Income Tax	0.16	-0	0.43	0.59	0.02	0.67
Net Income	-0.54	-8.48	-7.07	-1.45	-2.39	-6.38
Shares Outstanding (Basic)	16	14	11	12	9	9
Shares Outstanding (Diluted)	22	14	11	12	9	9
Shares Change	78.14%	20.18%	-2.40%	27.33%	-0.81%	14.14%
EPS (Basic)	-0.08	-0.62	-0.62	-0.12	-0.26	-0.69
EPS (Diluted)	-0.15	-0.62	-0.62	-0.12	-0.26	-0.69
Free Cash Flow	-2.33	-3.71	-2.11	-0.15	-0.59	-0.98
Free Cash Flow Per Share	-0.10	-0.27	-0.18	-0.01	-0.06	-0.11
Gross Margin	93.88%	91.07%	87.17%	66.03%	49.64%	49.83%
Operating Margin	-0.28%	-46.62%	-68.09%	-36.99%	-73.06%	-217.82%
Profit Margin	-0.92%	-50.84%	-102.90%	-33.30%	-94.75%	-242.69%
Free Cash Flow Margin	-4.02%	-22.23%	-30.64%	-3.51%	-23.21%	-37.23%
EBITDA	0.06	-7.55	-4.44	-1.29	-1.59	-5.39
EBITDA Margin	0.10%	-45.25%	-64.54%	-29.75%	-63.25%	-204.77%
Depreciation & Amortization	0.22	0.23	0.24	0.28	0.24	0.33
EBIT	-0.16	-7.78	-4.68	-1.58	-1.84	-5.72
EBIT Margin	-0.28%	-46.62%	-68.08%	-36.29%	-72.90%	-217.47%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.